OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pegylated Interferon α Therapy in Chronic Delta Hepatitis: A One-Center Experience
Ibrahim Halil Bahçecıoğlu, Murat İspiroğlu, Ulvi Demirel, et al.
Hepatitis Monthly (2015) Vol. 15, Iss. 3
Open Access | Times Cited: 19
Ibrahim Halil Bahçecıoğlu, Murat İspiroğlu, Ulvi Demirel, et al.
Hepatitis Monthly (2015) Vol. 15, Iss. 3
Open Access | Times Cited: 19
Showing 19 citing articles:
Interferon‐based treatment of chronic hepatitis D
Lisa Sandmann, Heiner Wedemeyer
Liver International (2022) Vol. 43, Iss. S1, pp. 69-79
Open Access | Times Cited: 43
Lisa Sandmann, Heiner Wedemeyer
Liver International (2022) Vol. 43, Iss. S1, pp. 69-79
Open Access | Times Cited: 43
Current and future therapeutic options for chronic hepatitis D virus infection
Mariantonietta Pisaturo, Giovanna Russo, Pierantonio Grimaldi, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access
Mariantonietta Pisaturo, Giovanna Russo, Pierantonio Grimaldi, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access
Effectiveness of pegylated interferon monotherapy in the treatment of chronic hepatitis D virus infection: A meta-analysis
Aigerim Abdrakhman, Aiymkul Ashimkhanova, Wassim Y. Almawi
Antiviral Research (2020) Vol. 185, pp. 104995-104995
Closed Access | Times Cited: 33
Aigerim Abdrakhman, Aiymkul Ashimkhanova, Wassim Y. Almawi
Antiviral Research (2020) Vol. 185, pp. 104995-104995
Closed Access | Times Cited: 33
Hepatitis delta and HIV infection
Vincent Soriano, Kenneth E. Sherman, Pablo Barreiro
AIDS (2017) Vol. 31, Iss. 7, pp. 875-884
Closed Access | Times Cited: 38
Vincent Soriano, Kenneth E. Sherman, Pablo Barreiro
AIDS (2017) Vol. 31, Iss. 7, pp. 875-884
Closed Access | Times Cited: 38
Treatment of chronic hepatitis due to hepatitis B and hepatitis delta virus coinfection
Giuseppina Brancaccio, Giovanni Battista Gaeta
International Journal of Antimicrobial Agents (2019) Vol. 54, Iss. 6, pp. 697-701
Closed Access | Times Cited: 14
Giuseppina Brancaccio, Giovanni Battista Gaeta
International Journal of Antimicrobial Agents (2019) Vol. 54, Iss. 6, pp. 697-701
Closed Access | Times Cited: 14
Results of Response-Guided Therapy with Pegylated Interferon Alpha 2a in Chronic Hepatitis B and D
George Sebastian Gherlan, Ştefan Lazăr, Augustina Culinescu, et al.
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 4, pp. 73-73
Open Access | Times Cited: 1
George Sebastian Gherlan, Ştefan Lazăr, Augustina Culinescu, et al.
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 4, pp. 73-73
Open Access | Times Cited: 1
Treatment of Delta Hepatitis: Today and in the Future - A review
Ibrahim Halil Bahçecıoğlu, Abdurrahman Şahin
Infectious Diseases (2017) Vol. 49, Iss. 4, pp. 241-250
Closed Access | Times Cited: 11
Ibrahim Halil Bahçecıoğlu, Abdurrahman Şahin
Infectious Diseases (2017) Vol. 49, Iss. 4, pp. 241-250
Closed Access | Times Cited: 11
Treatment endpoints for chronic hepatitis D
Olga Metin, Müjdat Zeybel, Cihan Yurdaydìn
Liver International (2022) Vol. 43, Iss. S1, pp. 60-68
Closed Access | Times Cited: 7
Olga Metin, Müjdat Zeybel, Cihan Yurdaydìn
Liver International (2022) Vol. 43, Iss. S1, pp. 60-68
Closed Access | Times Cited: 7
Prokaryotic Expression, Purification and Immunogenicity in Rabbits of the Small Antigen of Hepatitis Delta Virus
V. L. Tunitskaya, Olesja Eliseeva, Vladimir T. Valuev-Elliston, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 10, pp. 1721-1721
Open Access | Times Cited: 8
V. L. Tunitskaya, Olesja Eliseeva, Vladimir T. Valuev-Elliston, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 10, pp. 1721-1721
Open Access | Times Cited: 8
Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus Infection
Zhimin Guo, King T
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 8, pp. 19537-19552
Open Access | Times Cited: 7
Zhimin Guo, King T
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 8, pp. 19537-19552
Open Access | Times Cited: 7
The hepatitis D satellite virus of hepatitis B virus: half-opening a new era to control viral infection?
Natali Abeywickrama Samarakoon, Jc Cortay, Paul Dény
Current Opinion in Infectious Diseases (2016) Vol. 29, Iss. 6, pp. 645-653
Closed Access | Times Cited: 7
Natali Abeywickrama Samarakoon, Jc Cortay, Paul Dény
Current Opinion in Infectious Diseases (2016) Vol. 29, Iss. 6, pp. 645-653
Closed Access | Times Cited: 7
Future anti‐HDV treatment strategies, including those aimed at HBV functional cure
Yong Chuan Tan, Guan Huei Lee, Daniel Q. Huang, et al.
Liver International (2022) Vol. 43, Iss. 6, pp. 1157-1169
Closed Access | Times Cited: 5
Yong Chuan Tan, Guan Huei Lee, Daniel Q. Huang, et al.
Liver International (2022) Vol. 43, Iss. 6, pp. 1157-1169
Closed Access | Times Cited: 5
Dynamics of in vivo hepatitis D virus infection
Ashish Goyal, John M. Murray
Journal of Theoretical Biology (2016) Vol. 398, pp. 9-19
Closed Access | Times Cited: 6
Ashish Goyal, John M. Murray
Journal of Theoretical Biology (2016) Vol. 398, pp. 9-19
Closed Access | Times Cited: 6
Emerging drugs for hepatitis D
Onur Keskın, Cihan Yurdaydìn
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 2, pp. 55-66
Closed Access | Times Cited: 2
Onur Keskın, Cihan Yurdaydìn
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 2, pp. 55-66
Closed Access | Times Cited: 2
Treatment of HCV, HDV, or HIV Coinfection
Carla S. Coffin, Norah A. Terrault
Springer eBooks (2017), pp. 239-262
Closed Access | Times Cited: 2
Carla S. Coffin, Norah A. Terrault
Springer eBooks (2017), pp. 239-262
Closed Access | Times Cited: 2
Can We Predict Sustained Virologic Response to Interferon α Therapy in Patients With Chronic Hepatitis Delta Virus Infection?
Caroline Scholtès, Rajneesh Kumar, Fabien Zoulim
Clinical Gastroenterology and Hepatology (2015) Vol. 13, Iss. 13, pp. 2350-2352
Open Access | Times Cited: 1
Caroline Scholtès, Rajneesh Kumar, Fabien Zoulim
Clinical Gastroenterology and Hepatology (2015) Vol. 13, Iss. 13, pp. 2350-2352
Open Access | Times Cited: 1
Virological response of hepatitis Delta infection to treatment with Pegylated Interferon alpha 2a in a high prevalence country
Open Journal of Gastroenterology and Hepatology (2020), pp. 32-32
Open Access
Open Journal of Gastroenterology and Hepatology (2020), pp. 32-32
Open Access
Treatment of HCV, HDV, or HIV Coinfections
Kali Zhou, Norah A. Terrault
Springer eBooks (2021), pp. 339-373
Closed Access
Kali Zhou, Norah A. Terrault
Springer eBooks (2021), pp. 339-373
Closed Access
